![Training cover](https://storage.googleapis.com/platform-dev/uploads/files/ff1taKnkTa0gzo7dpo6L6D6xtQOKV9MKBwn84vRd.png)
Replay - Spirometry and Feno, Important diagnostic and monitoring tools for the Asthmatic patient.
Free
![Department Logo](https://storage.googleapis.com/platform-dev/uploads/files/39Ori8rOv2CV2ZcDJJPmAGfQu9EfqMh6s2oIEH0p.png)
About
01h00
English
There is increasing evidence that asthma is a heterogeneous pathological condition characterized by different phenotypes/endotypes related to specific pathological pathways. Exhaled nitric oxide (FeNO), is a biomarker of one pathologic pathway, allergic airway inflammation, that has proven helpful to predict therapeutic response in selected asthmatic populations. FeNO is a quantitative, non-invasive, simple and safe method of measuring allergic airway inflammation that provides a complementary tool to other ways of assessing airway disease in asthma patients including spirometry and as part of the diagnostic algorithm for both children over 5 and adults with respiratory symptoms suggestive of asthma, but has also demonstrated utility for managing asthma and selecting therapies for this disease. A common question is “How do FeNO and spirometry complement each other and why do I need both?”
During this webinar, our speaker Dr. Philip E Silkoff will try and answer this question by reviewing the current evidence on the relationship between FeNO & Spirometry and how these tools can be used together for the Asthmatic patients.
Speakers
![Speaker Avatar](https://storage.googleapis.com/platform-dev/uploads/avatars/avatar_1622207187.jpeg)
Audience
This event is for specialists below
Pulmonology
Respiratory Therapist
What you peers think about Vyaire Medical
Global review
Knowledge acquired
5.0
Organization
5.0
Pedagogy
5.0
Recommandation
5.0
Contact us
Chat with us
- Chat available in the bottom left corner
Free
![Department Logo](https://storage.googleapis.com/platform-dev/uploads/files/39Ori8rOv2CV2ZcDJJPmAGfQu9EfqMh6s2oIEH0p.png)